Assessing the impact of patient self‐selection on the costs to treat latent tuberculosis infection (LTBI) with isoniazid and transitional rifampin

By  

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 20, Iss. 5, 2014-10 ,pp. : 685-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

Donor‐derived tuberculosis (TB): isoniazid‐resistant TB transmitted from a lung transplant donor with inadequately treated latent infection

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 18, Iss. 5, 2016-10 ,pp. : 782-784

John Wiley & Sons Inc

Access to resources Recommend Favorite

Using Spatial Disease Patterns and Patient‐Level Characteristics to Describe Prevalence Elastic Behavior in Treatment for Latent Tuberculosis Infection (LTBI)

By  

PUBLIC HEALTH NURSING, Vol. 32, Iss. 5, 2015-09 ,pp. : 517-531

John Wiley & Sons Inc

Access to resources Recommend Favorite

A review of murine models of latent tuberculosis infection

By Shi Changhong   Shi Jieran   Xu Zhikai  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 11-12, 2011-12 ,pp. : 848-856

Informa Healthcare

Access to resources Recommend Favorite

Assessment of targeting accuracy of a low-energy stereotactic radiosurgery treatment for age-related macular degeneration

By Taddei Phillip J   Chell Erik   Hansen Steven   Gertner Michael   Newhauser Wayne D  

Physics in Medicine and Biology, Vol. 55, Iss. 23, 2010-12 ,pp. : 7037-7054

IOP Publishing

Access to resources Recommend Favorite